I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 23% ± 6% | |
| natural killer cell | 8 studies | 19% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 19% ± 3% | |
| gamma-delta T cell | 5 studies | 20% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 18% ± 3% | |
| mature NK T cell | 4 studies | 16% ± 0% | |
| epithelial cell | 4 studies | 29% ± 9% | |
| glutamatergic neuron | 4 studies | 45% ± 17% | |
| neuron | 4 studies | 27% ± 11% | |
| GABAergic neuron | 3 studies | 37% ± 8% | |
| platelet | 3 studies | 26% ± 3% | |
| megakaryocyte | 3 studies | 30% ± 6% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 26% ± 11% | |
| erythrocyte | 3 studies | 30% ± 17% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 19% ± 4% |
